LOXL2 and esophageal cancer: Intriguingly, only one of the LOXL2/L2Δ13-interacting proteins, aldolase A, was hyperacetylated in LOXL2-silenced esophageal cancer cells (Fig. 5C), while re-expression of LOXL2 or L2Δ13 reduced the elevated acetylation level of aldolase A (Fig. 5D).